MedPage Today January 7, 2022
— Medicare drug price negotiation, Part B redesign still on the table, analyst says
WASHINGTON — Although the prospects appear dim now for passage in Congress of the Build Back Better Act in its current form, a pared-down version may survive and is likely to include some health provisions, a policy expert said at a webinar sponsored by Avalere, a healthcare consulting firm.
“The legislation passed in the House is likely not to advance in its current form,” especially after Sen. Joe Manchin (D-W.Va.) said that he wouldn’t support the bill, Matt Kazan, MPP, principal at Avalere, said during Thursday’s webinar. “However, right now Democrats remain very motivated to get something done, and many have already talked about a more...
Today's Sponsors
Today's Sponsor